Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
AZD 7648 is a potent (IC50 = 0.6 nM in an enzyme assay) and selective DNA-PK inhibitor. It is selective for DNA-PK over a range of kinases including PI3Kα, PI3Kδ, PI3Kγ, ATM, ATR and mTOR. In combination with radiotherapy, it leads to tumor regression in fully immuno-competent mice models. It also enhances the activity of PARP inhibitor Olaparib (Cat. No. 7579). AZD 7648 is orally bioavailable.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
The following data is based on the product molecular weight 380.41. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.2 mM||13.14 mL||65.72 mL||131.44 mL|
|1 mM||2.63 mL||13.14 mL||26.29 mL|
|2 mM||1.31 mL||6.57 mL||13.14 mL|
|10 mM||0.26 mL||1.31 mL||2.63 mL|
References are publications that support the biological activity of the product.
Fok et al (2019) AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity. Nat.Commun. 10 5065 PMID: 31699977
Nakamura et al (2021) Inhibition of DNA-PK with AZD7648 sensitizes tumor cells to radiotherapy and induces type I IFN-dependent durable tumor control. Clin.Cancer Res. 27 4353 PMID: 34011558
Goldberg et al (2020) The discovery of 7-methyl-2-[(7-methyl[1,2,4]triazolo[1,5- a]pyridin-6-yl)amino]-9-(tetrahydro-2 H-pyran-4-yl)-7,9-dihydro-8 H-purin-8-one (AZD7648), a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor. J.Med.Chem. 63 3461 PMID: 31851518
Wimberger et al (2022) Simultaneous inhibition of DNA-PK and Polθ improves integration efficiency and precision of genome editing. bioRxiv - paper not yet peer reviewed
If you know of a relevant reference for AZD 7648, please let us know.
Keywords: AZD 7648, AZD 7648 supplier, AZD7648, potent, selective, DNA-dependent, protein, kinases, inhibitors, inhibits, DNA-PK, orally, bioavailable, Protein, Kinase, 7825, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for AZD 7648. Do you know of a great paper that uses AZD 7648 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review AZD 7648 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide provides a review of the cell cycle and DNA damage research area and lists over 170 products, including research tools for:
In normal cells, each stage of the cell cycle is tightly regulated, however in cancer cells many genes and proteins that are involved in the regulation of the cell cycle are mutated or over expressed. Adapted from the 2015 Cancer Product Guide, Edition 3, this poster summarizes the stages of the cell cycle and DNA repair. It also highlights strategies for enhancing replicative stress in cancer cells to force mitotic catastrophe and cell death.